Feasibility Assessment of Using CDISC Data Standards for In Silico Medical Device Trials-Reference-Cited by-同舟云学术

Feasibility Assessment of Using CDISC Data Standards for In Silico Medical Device Trials

Published:2023-09-21 Issue:3 Volume:3 Page:
ISSN:2694-1473
Container-title:Journal of the Society for Clinical Data Management
language:
Short-container-title:

Author:

Aydin Burç¹,Kiely Eanna²,Ohmann Christian³

Affiliation:

1. ECRIN

2. ClinBuild

3. ECRIN, ECRIN

Abstract

This report summarizes the current applicable regulatory framework and CDISC data standards for in vivo and in silico medical device randomized clinical trials, with an emphasis on transcatheter aortic valve replacement devices (TAVI). Trial Implementation issues and scenarios are discussed as well. This report has been prepared within the Horizon 2020 programme ‘In-Silico testing and validation of Cardiovascular IMplantable devices‘ (SIMCOR, GAID: 101017578) project and would be of relevance for clinical development, data management, and regulatory submission teams.

Publisher

Society for Clinical Management

Subject

General Medicine

Reference38 articles.

1. in silico Clinical Trials: How Computer Simulation Will Transform the Biomedical Industry;Viceconti MHenney AMorley-Fletcher E,2016

2. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC;Official Journal of the European Union,2017

3. 3. European Medicines Agency. Human regulatory – medical devices. Accessed February 21, 2022. https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices

4. 4. Heads of Medicines Agencies and European Medicines Agency. HMA-EMA Joint Big Data Taskforce – summary report. February 13, 2019. EMA/105321/2019. Accessed February 22, 2022. https://www.ema.europa.eu/en/documents/minutes/hma/ema-joint-task-force-big-data-summary-report_en.pdf

5. 5. Heads of Medicines Agencies and European Medicines Agency. European Medicines Regulatory Network Data Standardisation Strategy. December 16, 2021. EMA/447502/2021. Accessed February 22, 2022. https://www.ema.europa.eu/en/documents/other/european-medicines-regulatory-network-data-standardisation-strategy_en.pdf